NWCAX
Price
$52.85
Change
+$0.33 (+0.63%)
Updated
May 8 closing price
Net Assets
831.3M
RGABX
Price
$64.63
Change
+$0.47 (+0.73%)
Updated
May 8 closing price
Net Assets
283.8B
Ad is loading...

NWCAX vs RGABX

Header iconNWCAX vs RGABX Comparison
Open Charts NWCAX vs RGABXBanner chart's image
Nuveen Winslow Large-Cap Growth ESG A
Price$52.85
Change+$0.33 (+0.63%)
VolumeN/A
Net Assets831.3M
American Funds Growth Fund of Amer R2
Price$64.63
Change+$0.47 (+0.73%)
VolumeN/A
Net Assets283.8B
NWCAX vs RGABX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NWCAX vs. RGABX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NWCAX is a Buy and RGABX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RGABX has more cash in the bank: 284B vs. NWCAX (831M). NWCAX (0.00) and RGABX (0.00) have matching dividends . NWCAX was incepted earlier than RGABX: NWCAX (16 years) vs RGABX (23 years). RGABX (1.39) is less costly to investors than NWCAX (1.08). NWCAX is a more actively managed with annual turnover of: 56.00 vs. RGABX (25.00). RGABX has a lower initial minimum investment than NWCAX: RGABX (250) vs NWCAX (2500). RGABX annual gain was more profitable for investors over the last year : 1.96 vs. NWCAX (-6.03). RGABX return over 5 years is better than : 36.12 vs. NWCAX (30.03).
NWCAXRGABXNWCAX / RGABX
Total Expense Ratio0.901.3965%
Annual Report Gross Expense Ratio1.081.3978%
Fund Existence16 years23 years-
Gain YTD-6.030-2.695224%
Front Load6%N/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets831M284B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year-6.031.96-308%
Returns for 3 years28.8229.2199%
Returns for 5 years30.0336.1283%
Returns for 10 years16.9748.3735%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACAD16.932.39
+16.44%
ACADIA Pharmaceuticals
XP17.591.75
+11.05%
XP
ACRS1.310.06
+4.80%
Aclaris Therapeutics
DAKT13.950.31
+2.27%
Daktronics
NLSP1.65-0.05
-2.94%
Nls Pharmaceutics Ltd